FDA Approves Stivarga for Advanced Gastrointestinal Stromal Tumors

February 25, 2013 -- The U.S. Food and Drug Administration today expanded the approved use of Stivarga (regorafenib) to treat patients with advanced gastrointestinal stromal tumors (GIST) that cannot be surgically removed and no longer respond to...

http://feeds.drugs.com/~r/Drugscom-NewDrugApprovals/~3/m3lCZWYrWCw/fda-approves-...

Source: Drugs.com - New Drug Approvals - February 25, 2013 Category: Drugs & Pharmacology Source Type: news

More News: Drugs & Pharmacology | Food and Drug Administration (FDA) | Gastroenterology | Gastrointestinal Stromal Tumor (GIST)